H.R. 2199 119th Congress
Restore Protections for Dialysis Patients Act
- Health
- Sponsor: Rep. Kelly, Mike [R-PA-16]
- Congress.gov ↗
Latest action, Mar 18, 2025: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
94 cosponsors
Sponsored by Rep. Kelly, Mike [R-PA-16] (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
All 25 of 37 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | 7 | $28.6M | Q1 2025 | Q3 2026 | yes | |
| DAVITA INC | CAPITOL HILL CONSULTING GROUP | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| DAVITA INC | 7 | $7.6M | Q1 2025 | Q3 2026 | yes | |
| DAVITA INC. | RED+BLUE STRATEGIES | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| DAVITA, INC | APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL) | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| DAVITA, INC. | FEDERAL STREET STRATEGIES, LLC | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| DIALYSIS PATIENT CITIZENS | KOUNTOUPES DENHAM CARR & REID, LLC | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| DIALYSIS PATIENT CITIZENS | 7 | $2.3M | Q1 2025 | Q3 2026 | yes | |
| FRESENIUS MEDICAL CARE NORTH AMERICA | 7 | $8.6M | Q1 2025 | Q3 2026 | yes | |
| FRESENIUS MEDICAL CARE NORTH AMERICA | AVENUE SOLUTIONS | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| KIDNEY CARE PARTNERS | FEDERAL HEALTH POLICY STRATEGIES | 7 | $560K | Q1 2025 | Q3 2026 | yes |
| U.S. RENAL CARE | JEFFREY J. KIMBELL & ASSOCIATES, INC. | 7 | $350K | Q1 2025 | Q3 2026 | yes |
| AKEBIA THERAPEUTICS, INC. | 6 | $2.1M | Q1 2025 | Q2 2026 | yes | |
| AMERICAN ASSOCIATION OF NURSE PRACTITIONERS | 6 | $2.5M | Q4 2025 | Q3 2026 | yes | |
| SERVICE EMPLOYEES INTERNATIONAL UNION | NVG, LLC | 6 | $510K | Q4 2025 | Q3 2026 | yes |
| SERVICE EMPLOYEES INTERNATIONAL UNION CTW-CLC | 6 | $1.7M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN KIDNEY FUND | 5 | $1.0M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN NEPHROLOGY NURSES ASSOCIATION | VENABLE LLP | 5 | $150K | Q4 2025 | Q3 2026 | yes |
| KIDNEY CARE ACCESS COLAITION, INC. | CHECKMATE GOVERNMENT RELATIONS | 5 | $370K | Q4 2025 | Q2 2026 | yes |
| KIDNEY CARE PARTNERS | AVENUE SOLUTIONS | 5 | $380K | Q1 2025 | Q1 2026 | yes |
| KIDNEY CARE COUNCIL | RS GROUP CONSULTING LLC | 4 | $60K | Q4 2025 | Q3 2026 | yes |
| AMERICAN BENEFITS COUNCIL | 3 | $830K | Q1 2026 | Q3 2026 | yes | |
| THE ROGOSIN INSTITUTE | THE FERRARO GROUP | 3 | $90K | Q1 2026 | Q3 2026 | yes |
| U.S. RENAL CARE | LESTER HEALTH LAW PLLC | 3 | $91K | Q1 2026 | Q3 2026 | yes |
| AFL-CIO | 2 | $1.7M | Q2 2026 | Q3 2026 | yes |